JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 21 No. 9 852-858
© 1980 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Counsell, R. E.
Right arrow Articles by Huler, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Counsell, R. E.
Right arrow Articles by Huler, R. J.

Tissue Distribution of High-Density Lipoprotein Labeled with Radioiodinated Cholesterol

Raymond E. Counsell, Lawrence W. Schappa, Nancy Korn and Robert J. Huler

University of Michigan Medical School, Ann Arbor, Michigan

Correspondence: For reprints contact: R. E. Counsell, PhD, Dept. of Pharmacology, Univ. of Michigan Medical School, Ann Arbor, MI 48109.

ABSTRACT

This preliminary study was undertaken in order to explore possible methods for enhancing the target organ specificity of radioiodinated cholesterol. 19-[125I]cholesterol (I*C) was rapidly incorporated and transported in high-density lipoproteins (HDL) following i.v. administration to rats, and thus behaved like cholesterol in this regard. Incorporation of I*C into HDL (I*C-HDL) before administration produced little change in the tissue distribution profile except for a reduction in the amount of radioactivity appearing in the thyroid. This suggested that the lipoprotein carrier may have afforded protection from metabolic dehalogenation of I*C. When rats were pretreated with 4-aminopyrazolo-(3,4d)-pyrimidine to drastically reduce the circulating lipoprotein levels, a fourfold enhancement in adrenal uptake was observed following administration of I*C-HDL. This finding was consistent with the current view that the rat adrenal contains high-affinity and saturable receptors for HDL.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1980 by the Society of Nuclear Medicine.